Abstract
AbstractThe cell‐surface receptor CD44 has collected a library of diverse functionalities represented across multiple facets of health and disease. Recent revelations by Kim et al. indicate the importance of CD44 and its interacting proteins in the governance over critical hepatocyte cell processes, which promote liver tissue regeneration. In this commentary, we discuss prospective solutions for targeting of CD44 via its variant isoforms to elicit therapeutic outcomes. We also provide examples of targeting and exploiting CD44 variant candidates, as well as their shared hyaluronan binding function, for the purpose of achieving preventative and regenerative therapies.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
